Beth & PoNS Therapy

Hear PoNS™ patient Beth Foster's story.
This is intended for a Canadian audience.
Hear how PoNS trainer, Dr. Ryan Scott has implemented PoNS Therapy™ into his clinic.
PoNS™ is authorized for sale in Canada for three indications: (i) for use as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (“mmTBI”) and is to be used in conjunction with physical therapy; and (ii) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS and is to be used in conjunction with physical therapy; and (iii) for use as a short-term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from stroke, to be used in conjunction with physical therapy.